{"gene":"ADD1","run_date":"2026-06-09T22:02:41","timeline":{"discoveries":[{"year":1993,"finding":"ADD1 is a novel basic helix-loop-helix leucine zipper transcription factor that binds sequence-specific DNA elements (including an E-box in the fatty acid synthase gene promoter) and functions as a transcriptional activator in adipocytes; its mRNA is expressed predominantly in brown adipose tissue and regulated during adipocyte determination and differentiation.","method":"Oligonucleotide screening of adipocyte cDNA expression library, chloramphenicol acetyltransferase reporter assays, DNA-binding specificity assays","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 1–2 / Strong — founding paper with multiple orthogonal methods: DNA-binding assays, transcriptional reporter assays, expression analysis; replicated by subsequent work","pmids":["8336713"],"is_preprint":false},{"year":1995,"finding":"ADD1/SREBP1 has dual DNA-binding specificity, recognizing both a canonical E-box (ATCACGTGA) and the non-E-box sterol regulatory element SRE-1 (ATCACCCCAC); this dual specificity is controlled by a single atypical tyrosine residue in the basic region of the bHLH domain — substituting this tyrosine with arginine (found in most bHLH proteins) restricts binding to E-box only, while introducing tyrosine into upstream stimulatory factor confers dual binding.","method":"PCR-amplified binding analysis, site-directed mutagenesis of the bHLH basic region, transcriptional reporter assays in fibroblasts","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 1 / Strong — reconstitution-level mutagenesis with functional validation, bidirectional swap mutations confirming the mechanism","pmids":["7739539"],"is_preprint":false},{"year":1998,"finding":"ADD1/SREBP1 activates PPARγ specifically (not PPARα or PPARδ) through the PPARγ ligand-binding domain by stimulating production and secretion of endogenous lipid ligand(s) that directly bind PPARγ and displace radiolabeled thiazolidinedione; this ligand production does not require coexpression in the same cell.","method":"Gal4-PPARγ chimeric reporter assays, conditioned medium transfer experiments, radioligand displacement binding assay","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1–2 / Strong — multiple orthogonal methods including ligand displacement binding assay and conditioned medium transfer; mechanistically definitive","pmids":["9539737"],"is_preprint":false},{"year":1999,"finding":"Id2 and Id3 (dominant-negative HLH proteins) physically interact with ADD1/SREBP1c in the absence of DNA, inhibit formation of ADD1-DNA complexes on the fatty acid synthase promoter E-box, and functionally antagonize ADD1/SREBP1c transcriptional activation of the FAS promoter; antisense Id3 potentiated the ADD1 effect.","method":"Co-immunoprecipitation of in vitro-translated proteins, gel mobility shift assay, transient transfection reporter assays in adipocytes and NIH-3T3 cells","journal":"The Biochemical journal","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — reciprocal co-IP plus functional reporter assays in two cell lines, single lab","pmids":["10585876"],"is_preprint":false},{"year":2003,"finding":"Twist2 (Dermo-1), identified by yeast two-hybrid screening, physically interacts with the N-terminal domain of ADD1/SREBP1c and represses its transcriptional activity primarily by reducing ADD1 binding to target DNA sequences; HDAC inhibitors relieve this repression, indicating chromatin modification contributes to the mechanism.","method":"Yeast two-hybrid screening with adipocyte cDNA library, co-immunoprecipitation, DNA-binding assays, transcriptional reporter assays, HDAC inhibitor treatment","journal":"Nucleic acids research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — yeast two-hybrid plus co-IP plus functional reporter and DNA-binding assays; single lab","pmids":["14654692"],"is_preprint":false},{"year":2004,"finding":"GSK3β negatively regulates ADD1/SREBP1c transcriptional activity by directly phosphorylating it in vitro and in vivo; GSK3 inhibitors enhance ADD1/SREBP1c target gene expression (FAS, ACC1, SCD1) without requiring new protein synthesis, and overexpression of GSK3β suppresses ADD1/SREBP1c transcriptional activity.","method":"In vitro kinase assay, in vivo phosphorylation assay, GSK3 inhibitor treatment, GSK3β overexpression, transcriptional reporter assays, target gene expression analysis","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Moderate — in vitro kinase assay plus in vivo phosphorylation plus gain/loss of function reporter assays; multiple orthogonal methods in single lab","pmids":["15466874"],"is_preprint":false},{"year":2005,"finding":"ADD1/SREBP1c directly regulates mouse 6-phosphogluconate dehydrogenase (6PGDH) gene expression through an E-box motif in its promoter; DNase I footprinting and point mutation of the E-box abolished ADD1-dependent activation; PI3-kinase acts as an upstream linker for insulin-dependent ADD1/SREBP1c-mediated 6PGDH expression.","method":"DNase I footprinting, promoter point mutation, transcriptional reporter assays, PI3-kinase inhibitor treatment","journal":"Biochemical and biophysical research communications","confidence":"Medium","confidence_rationale":"Tier 1–2 / Moderate — footprinting plus mutagenesis plus pharmacological pathway dissection; single lab","pmids":["15896329"],"is_preprint":false},{"year":2009,"finding":"ADD1/SREBP1c activates PGC1α promoter expression via a conserved E-box in the proximal PGC1α promoter; chromatin immunoprecipitation showed β-adrenergic stimulation recruits ADD1/SREBP1c to this E-box in brown-like adipocytes; the activation is cell-type dependent, suggesting requirement for additional cell-restricted co-factors.","method":"Transcriptional reporter assays, chromatin immunoprecipitation (ChIP), β-adrenergic stimulation in in vitro adipocyte models","journal":"Biochimica et biophysica acta","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP plus reporter assays plus pharmacological stimulation; single lab, two orthogonal methods","pmids":["19962449"],"is_preprint":false},{"year":2012,"finding":"In C. elegans, loss of add-1 (α-adducin) function selectively impaired short- and long-term aversive olfactory memory without affecting acquisition, sensory, or motor function; ADD-1 is required for consolidation of synaptic plasticity and sustained synaptic increase of AMPA-type glutamate receptor (GLR-1) content; ADD-1 controls memory storage through actin-capping activity in a splice-form- and tissue-specific manner; human ADD1 expressed in nematodes rescued loss of C. elegans add-1 function.","method":"C. elegans loss-of-function genetic analysis, behavioral assays (olfactory conditioning), fluorescence microscopy of GLR-1 synaptic content, FRAP for GLR-1 turnover dynamics, human ADD1 rescue experiment","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal methods (genetics, imaging, behavioral assays, cross-species rescue); replicated in nematode and supported by human genetic association","pmids":["22307086"],"is_preprint":false},{"year":2012,"finding":"Add1 knockout mice on an inbred 129 background develop hyperkyphosis with complete penetrance and a subset develop severe megaesophagus; peripheral nerve examination reveals reduced axon number at 4 months; these non-erythroid phenotypes reveal previously unknown roles for α-adducin in neuronal and esophageal tissue.","method":"Add1 null (knockout) mouse strain analysis, histological examination of spine and esophagus, peripheral nerve axon counts","journal":"Genesis (New York, N.Y. : 2000)","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — clean knockout with specific phenotypic readouts in multiple tissues; single lab, no molecular mechanism identified","pmids":["22926980"],"is_preprint":false},{"year":2021,"finding":"Loss-of-function ADD1 variants in humans cause intellectual disability, corpus callosum dysgenesis, and ventriculomegaly; ADD1 is highly expressed in neocortex and corpus callosum with splice isoforms dynamically regulated between cortical progenitors and postmitotic neurons; patient variants impair ADD1 protein expression and/or dimerization with ADD2; Add1 knockout mice recapitulate corpus callosum dysgenesis and ventriculomegaly.","method":"Exome sequencing, RNA sequencing, super-resolution imaging, immunoblotting, in vitro dimerization assays (ADD1–ADD2), Add1 knockout mouse model","journal":"Genetics in medicine : official journal of the American College of Medical Genetics","confidence":"High","confidence_rationale":"Tier 2 / Strong — convergent human genetics with functional validation of variant proteins, dimerization assays, and mouse KO recapitulation; multiple orthogonal approaches","pmids":["34906466"],"is_preprint":false},{"year":2023,"finding":"ADD1 undergoes dephosphorylation and nuclear translocation downstream of CTSB S-nitrosylation, and nuclear ADD1 recruits MATR3 and ADAR1 to CTSB mRNA, enabling ADAR1-mediated A-to-I RNA editing that increases CTSB mRNA stability via HuR binding.","method":"S-nitrosylation assays, nuclear fractionation/localization assays, co-immunoprecipitation (ADD1–MATR3–ADAR1 complex), RNA editing assays, RNA stability assays, HuR binding assays","journal":"Cell research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — co-IP of complex plus localization plus functional RNA editing assays; single lab, multiple orthogonal methods but no independent replication","pmids":["37156877"],"is_preprint":false},{"year":2023,"finding":"ADD1/SREBP1c binds an E-box in the CHRDL1 gene upstream regulatory region and activates its transcription 2.6-fold; TWIST2 (but not TWIST2-Q119X mutant) competes with ADD1/SREBP1c for binding to the same E-box and blocks ADD1-mediated activation, whereas TWIST1 does not compete with ADD1/SREBP1c at this site.","method":"EMSA (electrophoretic mobility shift assay), luciferase reporter gene assays, EMSA competition assays with TWIST2/TWIST1 variants","journal":"Genes","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — EMSA plus reporter assays with multiple protein variants including disease mutants; single lab","pmids":["37761873"],"is_preprint":false},{"year":2024,"finding":"ADD1–3 adducins regulate the morphology and proliferative capacity of basal neural progenitors during neocortical development; overexpression of adducins in embryonic mouse neocortex increases basal progenitor protrusions and their proliferation and neuronal output; ADD1 knockout in human cortical organoids reduces progenitor proliferation and causes aberrant neurogenesis.","method":"In vivo mouse neocortex electroporation (overexpression), ferret neocortex in vivo experiments, human cortical organoid ADD1 knockout, immunofluorescence, cell counting","journal":"bioRxiv","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — in vivo and organoid loss/gain-of-function with cellular phenotype readouts; preprint, not yet peer-reviewed","pmids":["bio_10.1101_2024.11.08.622634"],"is_preprint":true},{"year":2004,"finding":"In congenic rat strains, introgression of the Milan hypertensive strain (MHS) Add1 gene into normotensive (MNS) background raised systolic blood pressure by ~10 mmHg, and replacing MHS Add1 with the MNS allele lowered SBP by ~10 mmHg, accounting for ~43% of the blood pressure difference between strains; Add2 and Add3 congenic strains showed no blood pressure effect.","method":"Reciprocal congenic strain development and blood pressure measurement (systolic blood pressure), chromosomal substitution mapping","journal":"Biochemical and biophysical research communications","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic epistasis via reciprocal congenic strains with quantitative phenotype; single lab, clean experimental design","pmids":["15474463"],"is_preprint":false}],"current_model":"ADD1 (α-adducin/SREBP1c) is a dual-function protein: in metabolic contexts it acts as a bHLH-leucine zipper transcription factor that binds E-box and SRE-1 elements (via a critical tyrosine in its basic domain) to activate lipogenic genes (FAS, ACC1, SCD1, 6PGDH) and PGC1α, produce PPARγ endogenous ligands, and is repressed by GSK3β-mediated phosphorylation and by physical interactions with Id2/Id3 and Twist2; in neuronal contexts it functions as an actin-capping/cytoskeletal protein required for synaptic AMPA receptor stabilization, memory consolidation, neural progenitor proliferation, and corpus callosum development, with ADD1 loss-of-function variants causing intellectual disability and brain malformations in humans."},"narrative":{"mechanistic_narrative":"ADD1 encodes a dual-function protein that operates both as a sequence-specific transcription factor controlling lipogenic gene programs and, in distinct cellular contexts, as a cytoskeletal adducin governing neural development and synaptic plasticity [PMID:8336713, PMID:22307086, PMID:34906466]. As a basic helix-loop-helix leucine zipper factor, ADD1/SREBP1 binds DNA through an atypical tyrosine in its basic region that confers dual recognition of canonical E-boxes and the non-E-box sterol regulatory element SRE-1 [PMID:7739539], enabling direct transcriptional activation of lipogenic and metabolic targets including fatty acid synthase, ACC1, SCD1, 6-phosphogluconate dehydrogenase, and PGC1α [PMID:8336713, PMID:15466874, PMID:15896329, PMID:19962449]. It further drives adipogenic signaling by stimulating production of secreted endogenous lipid ligands that directly activate PPARγ [PMID:9539737]. This transcriptional output is negatively regulated by GSK3β-mediated phosphorylation [PMID:15466874] and by physical interactions with the dominant-negative HLH proteins Id2/Id3 and with Twist2, which block ADD1 DNA binding [PMID:10585876, PMID:14654692, PMID:37761873]. In neural contexts, ADD1 functions through actin-capping activity to consolidate synaptic plasticity and stabilize AMPA-type glutamate receptors [PMID:22307086], and to control the morphology and proliferation of neocortical progenitors [PMID:bio_10.1101_2024.11.08.622634]. Human loss-of-function ADD1 variants cause intellectual disability, corpus callosum dysgenesis, and ventriculomegaly, phenotypes recapitulated in Add1 knockout mice, with patient variants impairing ADD1 protein expression and dimerization with ADD2 [PMID:34906466]. ADD1 additionally translocates to the nucleus downstream of CTSB S-nitrosylation to recruit MATR3 and ADAR1, promoting A-to-I editing and stabilization of CTSB mRNA [PMID:37156877].","teleology":[{"year":1993,"claim":"Established ADD1 as a novel bHLH-leucine zipper transcription factor that binds DNA and activates transcription in adipocytes, defining its identity as a sequence-specific regulator of adipogenic gene expression.","evidence":"Oligonucleotide cDNA library screening, CAT reporter assays, and DNA-binding specificity assays in adipocytes","pmids":["8336713"],"confidence":"High","gaps":["Did not define the full target gene set","No structural basis for DNA recognition"]},{"year":1995,"claim":"Resolved how ADD1 achieves dual DNA-binding specificity, showing a single atypical tyrosine in the basic region permits recognition of both E-box and SRE-1 elements, distinguishing it from canonical E-box-only bHLH factors.","evidence":"Site-directed mutagenesis of the bHLH basic region with bidirectional swap mutations and reporter assays in fibroblasts","pmids":["7739539"],"confidence":"High","gaps":["Did not establish which target genes use E-box versus SRE-1 in vivo"]},{"year":1998,"claim":"Showed ADD1 acts upstream of PPARγ by inducing secreted endogenous lipid ligands, linking ADD1 transcriptional activity to a paracrine adipogenic signaling axis.","evidence":"Gal4-PPARγ chimeric reporter assays, conditioned medium transfer, and radioligand displacement binding","pmids":["9539737"],"confidence":"High","gaps":["Chemical identity of the endogenous ligand(s) not determined","Biosynthetic enzymes downstream of ADD1 unidentified"]},{"year":1999,"claim":"Identified Id2/Id3 as dominant-negative HLH antagonists that sequester ADD1 away from DNA, providing a mechanism for negative control of lipogenic activation.","evidence":"Reciprocal co-IP of in vitro-translated proteins, gel shift, and reporter assays in adipocytes and NIH-3T3 cells","pmids":["10585876"],"confidence":"Medium","gaps":["Single lab","Physiological conditions controlling Id2/Id3 levels not addressed"]},{"year":2003,"claim":"Established Twist2 as an N-terminal-binding repressor of ADD1 that reduces DNA binding with a chromatin-modifying component, expanding the repertoire of ADD1 transcriptional repressors.","evidence":"Yeast two-hybrid screen, co-IP, DNA-binding and reporter assays, and HDAC inhibitor treatment","pmids":["14654692"],"confidence":"Medium","gaps":["Single lab","Identity of recruited HDAC not defined"]},{"year":2004,"claim":"Demonstrated GSK3β directly phosphorylates ADD1 to suppress its transcriptional output, placing ADD1 under kinase-dependent post-translational control of lipogenesis.","evidence":"In vitro kinase and in vivo phosphorylation assays, GSK3 inhibition, GSK3β overexpression, and target gene readouts","pmids":["15466874"],"confidence":"High","gaps":["Phosphorylation sites not mapped","Upstream signals controlling GSK3β toward ADD1 unclear"]},{"year":2004,"claim":"Showed via reciprocal congenic rat strains that Add1 allelic variation causally contributes to blood pressure regulation, distinguishing it functionally from Add2 and Add3.","evidence":"Reciprocal congenic strain construction and systolic blood pressure measurement with chromosomal substitution mapping","pmids":["15474463"],"confidence":"Medium","gaps":["Molecular mechanism linking Add1 allele to blood pressure not defined","Relationship to transcription factor vs cytoskeletal function unresolved"]},{"year":2005,"claim":"Connected ADD1 to insulin/PI3-kinase signaling by demonstrating direct E-box-dependent activation of the 6PGDH gene, extending its targets to the pentose phosphate pathway.","evidence":"DNase I footprinting, promoter point mutation, reporter assays, and PI3-kinase inhibitor treatment","pmids":["15896329"],"confidence":"Medium","gaps":["Single lab","Direct phosphorylation events linking PI3K to ADD1 not shown"]},{"year":2009,"claim":"Showed β-adrenergic signaling recruits ADD1 to a conserved E-box in the PGC1α promoter, linking ADD1 to thermogenic/mitochondrial transcriptional programs in brown-like adipocytes.","evidence":"Reporter assays, ChIP, and β-adrenergic stimulation in adipocyte models","pmids":["19962449"],"confidence":"Medium","gaps":["Cell-type-restricted cofactors required for activation unidentified","Single lab"]},{"year":2012,"claim":"Revealed a distinct cytoskeletal role for ADD1 in neurons, showing α-adducin actin-capping activity is required to consolidate synaptic plasticity and stabilize AMPA receptors during memory storage.","evidence":"C. elegans add-1 loss-of-function genetics, olfactory conditioning behavior, GLR-1 imaging and FRAP, and human ADD1 rescue","pmids":["22307086"],"confidence":"High","gaps":["Mechanistic link between actin-capping and receptor retention not fully resolved","Mammalian synaptic validation limited"]},{"year":2012,"claim":"Defined non-erythroid requirements for α-adducin in vivo, with Add1 knockout mice showing skeletal, esophageal, and peripheral nerve phenotypes.","evidence":"Add1 null mouse histology of spine and esophagus and peripheral nerve axon counts","pmids":["22926980"],"confidence":"Medium","gaps":["No molecular mechanism identified","Tissue-specific contributions not dissected"]},{"year":2021,"claim":"Established ADD1 as a human disease gene, with loss-of-function variants causing intellectual disability and brain malformations through impaired ADD1 expression and ADD2 dimerization.","evidence":"Exome and RNA sequencing, super-resolution imaging, immunoblotting, in vitro ADD1–ADD2 dimerization assays, and Add1 knockout mouse recapitulation","pmids":["34906466"],"confidence":"High","gaps":["Cellular mechanism linking dimerization loss to corpus callosum dysgenesis incomplete","Splice-isoform-specific functions not fully defined"]},{"year":2023,"claim":"Uncovered a nuclear RNA-regulatory function for ADD1, in which dephosphorylation-driven nuclear translocation recruits MATR3 and ADAR1 to promote A-to-I editing and stabilization of CTSB mRNA.","evidence":"S-nitrosylation assays, nuclear fractionation, co-IP of the ADD1–MATR3–ADAR1 complex, RNA editing and stability assays, and HuR binding assays","pmids":["37156877"],"confidence":"Medium","gaps":["Single lab without independent replication","Generality beyond CTSB unknown"]},{"year":2023,"claim":"Identified CHRDL1 as an ADD1 transcriptional target and showed TWIST2, but not TWIST1, competes at the shared E-box, refining the specificity of Twist-family repression of ADD1.","evidence":"EMSA, luciferase reporter assays, and EMSA competition with TWIST2/TWIST1 and disease-mutant variants","pmids":["37761873"],"confidence":"Medium","gaps":["Single lab","In vivo relevance of CHRDL1 regulation not established"]},{"year":2024,"claim":"Linked ADD1 to neocortical expansion by showing adducins regulate basal progenitor morphology and proliferative capacity across species.","evidence":"Mouse and ferret in vivo neocortex electroporation, human cortical organoid ADD1 knockout, and imaging/cell counting (preprint)","pmids":["bio_10.1101_2024.11.08.622634"],"confidence":"Medium","gaps":["Preprint, not yet peer-reviewed","Molecular mechanism connecting adducin to progenitor proliferation unresolved"]},{"year":null,"claim":"How the same protein partitions between its transcription-factor and cytoskeletal/RNA-regulatory roles, and what controls isoform- and tissue-specific deployment, remains unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No unified model reconciling metabolic transcription factor and neuronal adducin functions","Determinants of subcellular partitioning (nucleus vs cytoskeleton) undefined","Isoform-specific functional assignment incomplete"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0003677","term_label":"DNA binding","supporting_discovery_ids":[0,1,5,6,7,12]},{"term_id":"GO:0140110","term_label":"transcription regulator activity","supporting_discovery_ids":[0,2,5,7,12]},{"term_id":"GO:0008092","term_label":"cytoskeletal protein binding","supporting_discovery_ids":[8,13]}],"localization":[{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[11]},{"term_id":"GO:0005856","term_label":"cytoskeleton","supporting_discovery_ids":[8]}],"pathway":[{"term_id":"GO:0140110","term_label":"transcription regulator activity","supporting_discovery_ids":[0,5]}],"complexes":[],"partners":["PPARG","ID2","ID3","TWIST2","GSK3B","ADD2","MATR3","ADAR1"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"P35611","full_name":"Alpha-adducin","aliases":["Erythrocyte adducin subunit alpha"],"length_aa":737,"mass_kda":81.0,"function":"Membrane-cytoskeleton-associated protein that promotes the assembly of the spectrin-actin network. Binds to calmodulin","subcellular_location":"Cytoplasm, cytoskeleton; Cell membrane","url":"https://www.uniprot.org/uniprotkb/P35611/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/ADD1","classification":"Not Classified","n_dependent_lines":1,"n_total_lines":1208,"dependency_fraction":0.0008278145695364238},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[{"gene":"ACTB","stoichiometry":0.2},{"gene":"ACTG1","stoichiometry":0.2}],"url":"https://opencell.sf.czbiohub.org/search/ADD1","total_profiled":1310},"omim":[{"mim_id":"617008","title":"CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 3; CPSQ3","url":"https://www.omim.org/entry/617008"},{"mim_id":"613004","title":"HUNTINGTIN; HTT","url":"https://www.omim.org/entry/613004"},{"mim_id":"601568","title":"ADDUCIN 3; ADD3","url":"https://www.omim.org/entry/601568"},{"mim_id":"601510","title":"SREBP CLEAVAGE-ACTIVATING PROTEIN; SCAP","url":"https://www.omim.org/entry/601510"},{"mim_id":"145500","title":"HYPERTENSION, ESSENTIAL","url":"https://www.omim.org/entry/145500"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Enhanced","locations":[{"location":"Plasma membrane","reliability":"Enhanced"},{"location":"Nucleoplasm","reliability":"Additional"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/ADD1"},"hgnc":{"alias_symbol":[],"prev_symbol":[]},"alphafold":{"accession":"P35611","domains":[{"cath_id":"3.40.225.10","chopping":"134-336","consensus_level":"high","plddt":91.7825,"start":134,"end":336},{"cath_id":"1.10.287","chopping":"55-97","consensus_level":"medium","plddt":72.2063,"start":55,"end":97}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P35611","model_url":"https://alphafold.ebi.ac.uk/files/AF-P35611-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P35611-F1-predicted_aligned_error_v6.png","plddt_mean":64.88},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=ADD1","jax_strain_url":"https://www.jax.org/strain/search?query=ADD1"},"sequence":{"accession":"P35611","fasta_url":"https://rest.uniprot.org/uniprotkb/P35611.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P35611/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P35611"}},"corpus_meta":[{"pmid":"9539737","id":"PMC_9539737","title":"ADD1/SREBP1 activates PPARgamma through the production of endogenous ligand.","date":"1998","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/9539737","citation_count":557,"is_preprint":false},{"pmid":"8336713","id":"PMC_8336713","title":"ADD1: a novel helix-loop-helix transcription factor associated with adipocyte determination and differentiation.","date":"1993","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/8336713","citation_count":512,"is_preprint":false},{"pmid":"7739539","id":"PMC_7739539","title":"Dual DNA binding specificity of ADD1/SREBP1 controlled by a single amino acid in the basic helix-loop-helix domain.","date":"1995","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/7739539","citation_count":295,"is_preprint":false},{"pmid":"15466874","id":"PMC_15466874","title":"Regulatory role of glycogen synthase kinase 3 for transcriptional activity of ADD1/SREBP1c.","date":"2004","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15466874","citation_count":89,"is_preprint":false},{"pmid":"12052841","id":"PMC_12052841","title":"ADD1 460W allele associated with cardiovascular disease in hypertensive individuals.","date":"2002","source":"Hypertension (Dallas, Tex. : 1979)","url":"https://pubmed.ncbi.nlm.nih.gov/12052841","citation_count":63,"is_preprint":false},{"pmid":"10585876","id":"PMC_10585876","title":"Functional antagonism between inhibitor of DNA binding (Id) and adipocyte determination and differentiation factor 1/sterol regulatory element-binding protein-1c (ADD1/SREBP-1c) trans-factors for the regulation of fatty acid synthase promoter in adipocytes.","date":"1999","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/10585876","citation_count":62,"is_preprint":false},{"pmid":"14654692","id":"PMC_14654692","title":"Twist2, a novel ADD1/SREBP1c interacting protein, represses the transcriptional activity of ADD1/SREBP1c.","date":"2003","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/14654692","citation_count":49,"is_preprint":false},{"pmid":"22307086","id":"PMC_22307086","title":"A role for α-adducin (ADD-1) in nematode and human memory.","date":"2012","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/22307086","citation_count":49,"is_preprint":false},{"pmid":"23691048","id":"PMC_23691048","title":"Lower ADD1 gene promoter DNA methylation increases the risk of essential hypertension.","date":"2013","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/23691048","citation_count":48,"is_preprint":false},{"pmid":"10361996","id":"PMC_10361996","title":"Age-related adipose tissue mRNA expression of ADD1/SREBP1, PPARgamma, lipoprotein lipase, and GLUT4 glucose transporter in rhesus monkeys.","date":"1999","source":"The journals of gerontology. Series A, Biological sciences and medical sciences","url":"https://pubmed.ncbi.nlm.nih.gov/10361996","citation_count":40,"is_preprint":false},{"pmid":"31805646","id":"PMC_31805646","title":"DNA Methylation of Candidate Genes (ACE II, IFN-γ, AGTR 1, CKG, ADD1, SCNN1B and TLR2) in Essential Hypertension: A Systematic Review and Quantitative Evidence Synthesis.","date":"2019","source":"International journal of environmental research and public health","url":"https://pubmed.ncbi.nlm.nih.gov/31805646","citation_count":36,"is_preprint":false},{"pmid":"12885793","id":"PMC_12885793","title":"Interaction between ACE and ADD1 gene polymorphisms in the progression of IgA nephropathy in Japanese patients.","date":"2003","source":"Hypertension (Dallas, Tex. : 1979)","url":"https://pubmed.ncbi.nlm.nih.gov/12885793","citation_count":28,"is_preprint":false},{"pmid":"15474463","id":"PMC_15474463","title":"Effect of Add1 gene transfer on blood pressure in reciprocal congenic strains of Milan rats.","date":"2004","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/15474463","citation_count":27,"is_preprint":false},{"pmid":"21194526","id":"PMC_21194526","title":"A study of ACE and ADD1 polymorphism in ischemic and hemorrhagic stroke.","date":"2010","source":"Clinica chimica acta; international journal of clinical chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/21194526","citation_count":24,"is_preprint":false},{"pmid":"19962449","id":"PMC_19962449","title":"ADD1/SREBP1c activates the PGC1-alpha promoter in brown adipocytes.","date":"2009","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/19962449","citation_count":22,"is_preprint":false},{"pmid":"7959767","id":"PMC_7959767","title":"The murine homologues of the Huntington disease gene (Hdh) and the alpha-adducin gene (Add1) map to mouse chromosome 5 within a region of conserved synteny with human chromosome 4p16.3.","date":"1994","source":"Genomics","url":"https://pubmed.ncbi.nlm.nih.gov/7959767","citation_count":21,"is_preprint":false},{"pmid":"23863317","id":"PMC_23863317","title":"Effects of ACE and ADD1 gene polymorphisms on blood pressure response to hydrochlorothiazide: a meta-analysis.","date":"2013","source":"International journal of clinical pharmacology and therapeutics","url":"https://pubmed.ncbi.nlm.nih.gov/23863317","citation_count":20,"is_preprint":false},{"pmid":"16450155","id":"PMC_16450155","title":"Hydrochlorothiazide efficacy and polymorphisms in ACE, ADD1 and GNB3 in healthy, male volunteers.","date":"2006","source":"European journal of clinical pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/16450155","citation_count":20,"is_preprint":false},{"pmid":"15896329","id":"PMC_15896329","title":"Transcriptional regulation of mouse 6-phosphogluconate dehydrogenase by ADD1/SREBP1c.","date":"2005","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/15896329","citation_count":20,"is_preprint":false},{"pmid":"11309661","id":"PMC_11309661","title":"Identification of a mutation in ADD1/SREBP-1 in the spontaneously hypertensive rat.","date":"2001","source":"Mammalian genome : official journal of the International Mammalian Genome Society","url":"https://pubmed.ncbi.nlm.nih.gov/11309661","citation_count":16,"is_preprint":false},{"pmid":"25567773","id":"PMC_25567773","title":"The interactions between alcohol consumption and DNA methylation of the ADD1 gene promoter modulate essential hypertension susceptibility in a population-based, case-control study.","date":"2015","source":"Hypertension research : official journal of the Japanese Society of Hypertension","url":"https://pubmed.ncbi.nlm.nih.gov/25567773","citation_count":16,"is_preprint":false},{"pmid":"20838486","id":"PMC_20838486","title":"Gly460Trp polymorphism of the ADD1 gene and essential hypertension in an Indian population: A meta-analysis on hypertension risk.","date":"2010","source":"Indian journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/20838486","citation_count":16,"is_preprint":false},{"pmid":"11212213","id":"PMC_11212213","title":"Weight loss reduces expression of SREBP1c/ADD1 and PPARgamma2 in adipose tissue of obese women.","date":"2001","source":"Pflugers Archiv : European journal of physiology","url":"https://pubmed.ncbi.nlm.nih.gov/11212213","citation_count":15,"is_preprint":false},{"pmid":"37156877","id":"PMC_37156877","title":"Cathepsin B S-nitrosylation promotes ADAR1-mediated editing of its own mRNA transcript via an ADD1/MATR3 regulatory axis.","date":"2023","source":"Cell research","url":"https://pubmed.ncbi.nlm.nih.gov/37156877","citation_count":14,"is_preprint":false},{"pmid":"34906466","id":"PMC_34906466","title":"Variants in ADD1 cause intellectual disability, corpus callosum dysgenesis, and ventriculomegaly in humans.","date":"2021","source":"Genetics in medicine : official journal of the American College of Medical Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/34906466","citation_count":14,"is_preprint":false},{"pmid":"26042478","id":"PMC_26042478","title":"Association of alpha-ADD1 Gene and Hypertension Risk: A Meta-Analysis.","date":"2015","source":"Medical science monitor : international medical journal of experimental and clinical research","url":"https://pubmed.ncbi.nlm.nih.gov/26042478","citation_count":11,"is_preprint":false},{"pmid":"25816007","id":"PMC_25816007","title":"A phosphorylation-related variant ADD1-rs4963 modifies the risk of colorectal cancer.","date":"2015","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/25816007","citation_count":11,"is_preprint":false},{"pmid":"10429360","id":"PMC_10429360","title":"The ADD1 G460W polymorphism is not associated with variation in blood pressure in Canadian Oji-Cree.","date":"1999","source":"Journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/10429360","citation_count":11,"is_preprint":false},{"pmid":"27340988","id":"PMC_27340988","title":"Angiotensin-Converting Enzyme (ACE) I/D and Alpha-Adducin (ADD1) G460W Gene Polymorphisms in Turkish Patients with Severe Chronic Tinnitus.","date":"2016","source":"The journal of international advanced otology","url":"https://pubmed.ncbi.nlm.nih.gov/27340988","citation_count":11,"is_preprint":false},{"pmid":"9121491","id":"PMC_9121491","title":"An adipogenic basic helix-loop-helix-leucine zipper type transcription factor (ADD1) mRNA is expressed and regulated by retinoic acid in osteoblastic cells.","date":"1996","source":"Molecular endocrinology (Baltimore, Md.)","url":"https://pubmed.ncbi.nlm.nih.gov/9121491","citation_count":10,"is_preprint":false},{"pmid":"22810272","id":"PMC_22810272","title":"Computational study of ADD1 gene polymorphism associated with hypertension.","date":"2013","source":"Cell biochemistry and biophysics","url":"https://pubmed.ncbi.nlm.nih.gov/22810272","citation_count":8,"is_preprint":false},{"pmid":"32971583","id":"PMC_32971583","title":"Association of TBXA2R, P2Y12 and ADD1 genes polymorphisms with ischemic stroke susceptibility: A metaanalysis.","date":"2020","source":"Clinical and investigative medicine. Medecine clinique et experimentale","url":"https://pubmed.ncbi.nlm.nih.gov/32971583","citation_count":6,"is_preprint":false},{"pmid":"23540412","id":"PMC_23540412","title":"ACE and ADD1 gene in extra and intracranial atherosclerosis in ischaemic stroke.","date":"2013","source":"Neurological research","url":"https://pubmed.ncbi.nlm.nih.gov/23540412","citation_count":6,"is_preprint":false},{"pmid":"29049185","id":"PMC_29049185","title":"Relationship between ADD1 Gly460Trp gene polymorphism and essential hypertension in Madeira Island.","date":"2017","source":"Medicine","url":"https://pubmed.ncbi.nlm.nih.gov/29049185","citation_count":6,"is_preprint":false},{"pmid":"30062972","id":"PMC_30062972","title":"Alpha Adducin (ADD1) Gene Polymorphism and New Onset of Diabetes Under the Influence of Selective Antihypertensive Therapy in Essential Hypertension.","date":"2019","source":"Current hypertension reviews","url":"https://pubmed.ncbi.nlm.nih.gov/30062972","citation_count":6,"is_preprint":false},{"pmid":"20872252","id":"PMC_20872252","title":"A large indel mutation of the bovine ADD1/SREBP1c gene and its effects on growth traits in some native cattle breeds from China.","date":"2010","source":"Molecular biology reports","url":"https://pubmed.ncbi.nlm.nih.gov/20872252","citation_count":6,"is_preprint":false},{"pmid":"20473689","id":"PMC_20473689","title":"Polymorphisms in the GNB3 and ADD1 genes and blood pressure in a Chinese population.","date":"2010","source":"Human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/20473689","citation_count":5,"is_preprint":false},{"pmid":"22476228","id":"PMC_22476228","title":"Association between genetic variants of the ADD1 and GNB3 genes and blood pressure response to the cold pressor test in a Chinese Han population: the GenSalt Study.","date":"2012","source":"Hypertension research : official journal of the Japanese Society of Hypertension","url":"https://pubmed.ncbi.nlm.nih.gov/22476228","citation_count":5,"is_preprint":false},{"pmid":"34055401","id":"PMC_34055401","title":"The Association between Gly460Trp-Polymorphism of Alpha-Adducin 1 Gene (ADD1) and Arterial Hypertension Development in Ukrainian Population.","date":"2021","source":"International journal of hypertension","url":"https://pubmed.ncbi.nlm.nih.gov/34055401","citation_count":5,"is_preprint":false},{"pmid":"26535708","id":"PMC_26535708","title":"Development of FQ-PCR method to determine the level of ADD1 expression in fatty and lean pigs.","date":"2015","source":"Genetics and molecular research : GMR","url":"https://pubmed.ncbi.nlm.nih.gov/26535708","citation_count":3,"is_preprint":false},{"pmid":"22926980","id":"PMC_22926980","title":"Strain-specific hyperkyphosis and megaesophagus in Add1 null mice.","date":"2012","source":"Genesis (New York, N.Y. : 2000)","url":"https://pubmed.ncbi.nlm.nih.gov/22926980","citation_count":3,"is_preprint":false},{"pmid":"16520310","id":"PMC_16520310","title":"[Distributions of polymorphism of ADD1, MC4R, H-FABP gene, associated with IMF and BF in 3 populations in pig].","date":"2006","source":"Yi chuan = Hereditas","url":"https://pubmed.ncbi.nlm.nih.gov/16520310","citation_count":3,"is_preprint":false},{"pmid":"29527980","id":"PMC_29527980","title":"Genetic Variants in ADD1 Gene and their Associations with Growth Traits in Cattle.","date":"2018","source":"Animal biotechnology","url":"https://pubmed.ncbi.nlm.nih.gov/29527980","citation_count":2,"is_preprint":false},{"pmid":"37761873","id":"PMC_37761873","title":"Mechanisms of Regulation of the CHRDL1 Gene by the TWIST2 and ADD1/SREBP1c Transcription Factors.","date":"2023","source":"Genes","url":"https://pubmed.ncbi.nlm.nih.gov/37761873","citation_count":1,"is_preprint":false},{"pmid":"40421935","id":"PMC_40421935","title":"ICAM1 778G>A (rs1799969), ADD1 1378G>T (rs4961), NPPA 553T>C (rs5065), and NOS3 894G>T (rs1799983) Variants in Infants with Gastroschisis from Western Mexico.","date":"2025","source":"Genetic testing and molecular biomarkers","url":"https://pubmed.ncbi.nlm.nih.gov/40421935","citation_count":0,"is_preprint":false},{"pmid":null,"id":"bio_10.1101_2024.11.08.622634","title":"Adducins regulate morphology and fate of neural progenitors during neocortical neurogenesis","date":"2024-11-08","source":"bioRxiv","url":"https://doi.org/10.1101/2024.11.08.622634","citation_count":0,"is_preprint":true}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":24809,"output_tokens":4007,"usd":0.067266,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":12005,"output_tokens":4507,"usd":0.08635,"stage2_stop_reason":"end_turn"},"total_usd":0.153616,"stage1_batch_id":"msgbatch_0179Z2pxRYBsXi2xADneafRw","stage2_batch_id":"msgbatch_01LaY9ZaVdgjWArcZo9eqQE5","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1993,\n      \"finding\": \"ADD1 is a novel basic helix-loop-helix leucine zipper transcription factor that binds sequence-specific DNA elements (including an E-box in the fatty acid synthase gene promoter) and functions as a transcriptional activator in adipocytes; its mRNA is expressed predominantly in brown adipose tissue and regulated during adipocyte determination and differentiation.\",\n      \"method\": \"Oligonucleotide screening of adipocyte cDNA expression library, chloramphenicol acetyltransferase reporter assays, DNA-binding specificity assays\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Strong — founding paper with multiple orthogonal methods: DNA-binding assays, transcriptional reporter assays, expression analysis; replicated by subsequent work\",\n      \"pmids\": [\"8336713\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1995,\n      \"finding\": \"ADD1/SREBP1 has dual DNA-binding specificity, recognizing both a canonical E-box (ATCACGTGA) and the non-E-box sterol regulatory element SRE-1 (ATCACCCCAC); this dual specificity is controlled by a single atypical tyrosine residue in the basic region of the bHLH domain — substituting this tyrosine with arginine (found in most bHLH proteins) restricts binding to E-box only, while introducing tyrosine into upstream stimulatory factor confers dual binding.\",\n      \"method\": \"PCR-amplified binding analysis, site-directed mutagenesis of the bHLH basic region, transcriptional reporter assays in fibroblasts\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — reconstitution-level mutagenesis with functional validation, bidirectional swap mutations confirming the mechanism\",\n      \"pmids\": [\"7739539\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"ADD1/SREBP1 activates PPARγ specifically (not PPARα or PPARδ) through the PPARγ ligand-binding domain by stimulating production and secretion of endogenous lipid ligand(s) that directly bind PPARγ and displace radiolabeled thiazolidinedione; this ligand production does not require coexpression in the same cell.\",\n      \"method\": \"Gal4-PPARγ chimeric reporter assays, conditioned medium transfer experiments, radioligand displacement binding assay\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Strong — multiple orthogonal methods including ligand displacement binding assay and conditioned medium transfer; mechanistically definitive\",\n      \"pmids\": [\"9539737\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"Id2 and Id3 (dominant-negative HLH proteins) physically interact with ADD1/SREBP1c in the absence of DNA, inhibit formation of ADD1-DNA complexes on the fatty acid synthase promoter E-box, and functionally antagonize ADD1/SREBP1c transcriptional activation of the FAS promoter; antisense Id3 potentiated the ADD1 effect.\",\n      \"method\": \"Co-immunoprecipitation of in vitro-translated proteins, gel mobility shift assay, transient transfection reporter assays in adipocytes and NIH-3T3 cells\",\n      \"journal\": \"The Biochemical journal\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — reciprocal co-IP plus functional reporter assays in two cell lines, single lab\",\n      \"pmids\": [\"10585876\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"Twist2 (Dermo-1), identified by yeast two-hybrid screening, physically interacts with the N-terminal domain of ADD1/SREBP1c and represses its transcriptional activity primarily by reducing ADD1 binding to target DNA sequences; HDAC inhibitors relieve this repression, indicating chromatin modification contributes to the mechanism.\",\n      \"method\": \"Yeast two-hybrid screening with adipocyte cDNA library, co-immunoprecipitation, DNA-binding assays, transcriptional reporter assays, HDAC inhibitor treatment\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — yeast two-hybrid plus co-IP plus functional reporter and DNA-binding assays; single lab\",\n      \"pmids\": [\"14654692\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"GSK3β negatively regulates ADD1/SREBP1c transcriptional activity by directly phosphorylating it in vitro and in vivo; GSK3 inhibitors enhance ADD1/SREBP1c target gene expression (FAS, ACC1, SCD1) without requiring new protein synthesis, and overexpression of GSK3β suppresses ADD1/SREBP1c transcriptional activity.\",\n      \"method\": \"In vitro kinase assay, in vivo phosphorylation assay, GSK3 inhibitor treatment, GSK3β overexpression, transcriptional reporter assays, target gene expression analysis\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro kinase assay plus in vivo phosphorylation plus gain/loss of function reporter assays; multiple orthogonal methods in single lab\",\n      \"pmids\": [\"15466874\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"ADD1/SREBP1c directly regulates mouse 6-phosphogluconate dehydrogenase (6PGDH) gene expression through an E-box motif in its promoter; DNase I footprinting and point mutation of the E-box abolished ADD1-dependent activation; PI3-kinase acts as an upstream linker for insulin-dependent ADD1/SREBP1c-mediated 6PGDH expression.\",\n      \"method\": \"DNase I footprinting, promoter point mutation, transcriptional reporter assays, PI3-kinase inhibitor treatment\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1–2 / Moderate — footprinting plus mutagenesis plus pharmacological pathway dissection; single lab\",\n      \"pmids\": [\"15896329\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"ADD1/SREBP1c activates PGC1α promoter expression via a conserved E-box in the proximal PGC1α promoter; chromatin immunoprecipitation showed β-adrenergic stimulation recruits ADD1/SREBP1c to this E-box in brown-like adipocytes; the activation is cell-type dependent, suggesting requirement for additional cell-restricted co-factors.\",\n      \"method\": \"Transcriptional reporter assays, chromatin immunoprecipitation (ChIP), β-adrenergic stimulation in in vitro adipocyte models\",\n      \"journal\": \"Biochimica et biophysica acta\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP plus reporter assays plus pharmacological stimulation; single lab, two orthogonal methods\",\n      \"pmids\": [\"19962449\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"In C. elegans, loss of add-1 (α-adducin) function selectively impaired short- and long-term aversive olfactory memory without affecting acquisition, sensory, or motor function; ADD-1 is required for consolidation of synaptic plasticity and sustained synaptic increase of AMPA-type glutamate receptor (GLR-1) content; ADD-1 controls memory storage through actin-capping activity in a splice-form- and tissue-specific manner; human ADD1 expressed in nematodes rescued loss of C. elegans add-1 function.\",\n      \"method\": \"C. elegans loss-of-function genetic analysis, behavioral assays (olfactory conditioning), fluorescence microscopy of GLR-1 synaptic content, FRAP for GLR-1 turnover dynamics, human ADD1 rescue experiment\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal methods (genetics, imaging, behavioral assays, cross-species rescue); replicated in nematode and supported by human genetic association\",\n      \"pmids\": [\"22307086\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"Add1 knockout mice on an inbred 129 background develop hyperkyphosis with complete penetrance and a subset develop severe megaesophagus; peripheral nerve examination reveals reduced axon number at 4 months; these non-erythroid phenotypes reveal previously unknown roles for α-adducin in neuronal and esophageal tissue.\",\n      \"method\": \"Add1 null (knockout) mouse strain analysis, histological examination of spine and esophagus, peripheral nerve axon counts\",\n      \"journal\": \"Genesis (New York, N.Y. : 2000)\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — clean knockout with specific phenotypic readouts in multiple tissues; single lab, no molecular mechanism identified\",\n      \"pmids\": [\"22926980\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"Loss-of-function ADD1 variants in humans cause intellectual disability, corpus callosum dysgenesis, and ventriculomegaly; ADD1 is highly expressed in neocortex and corpus callosum with splice isoforms dynamically regulated between cortical progenitors and postmitotic neurons; patient variants impair ADD1 protein expression and/or dimerization with ADD2; Add1 knockout mice recapitulate corpus callosum dysgenesis and ventriculomegaly.\",\n      \"method\": \"Exome sequencing, RNA sequencing, super-resolution imaging, immunoblotting, in vitro dimerization assays (ADD1–ADD2), Add1 knockout mouse model\",\n      \"journal\": \"Genetics in medicine : official journal of the American College of Medical Genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — convergent human genetics with functional validation of variant proteins, dimerization assays, and mouse KO recapitulation; multiple orthogonal approaches\",\n      \"pmids\": [\"34906466\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"ADD1 undergoes dephosphorylation and nuclear translocation downstream of CTSB S-nitrosylation, and nuclear ADD1 recruits MATR3 and ADAR1 to CTSB mRNA, enabling ADAR1-mediated A-to-I RNA editing that increases CTSB mRNA stability via HuR binding.\",\n      \"method\": \"S-nitrosylation assays, nuclear fractionation/localization assays, co-immunoprecipitation (ADD1–MATR3–ADAR1 complex), RNA editing assays, RNA stability assays, HuR binding assays\",\n      \"journal\": \"Cell research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — co-IP of complex plus localization plus functional RNA editing assays; single lab, multiple orthogonal methods but no independent replication\",\n      \"pmids\": [\"37156877\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"ADD1/SREBP1c binds an E-box in the CHRDL1 gene upstream regulatory region and activates its transcription 2.6-fold; TWIST2 (but not TWIST2-Q119X mutant) competes with ADD1/SREBP1c for binding to the same E-box and blocks ADD1-mediated activation, whereas TWIST1 does not compete with ADD1/SREBP1c at this site.\",\n      \"method\": \"EMSA (electrophoretic mobility shift assay), luciferase reporter gene assays, EMSA competition assays with TWIST2/TWIST1 variants\",\n      \"journal\": \"Genes\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — EMSA plus reporter assays with multiple protein variants including disease mutants; single lab\",\n      \"pmids\": [\"37761873\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"ADD1–3 adducins regulate the morphology and proliferative capacity of basal neural progenitors during neocortical development; overexpression of adducins in embryonic mouse neocortex increases basal progenitor protrusions and their proliferation and neuronal output; ADD1 knockout in human cortical organoids reduces progenitor proliferation and causes aberrant neurogenesis.\",\n      \"method\": \"In vivo mouse neocortex electroporation (overexpression), ferret neocortex in vivo experiments, human cortical organoid ADD1 knockout, immunofluorescence, cell counting\",\n      \"journal\": \"bioRxiv\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vivo and organoid loss/gain-of-function with cellular phenotype readouts; preprint, not yet peer-reviewed\",\n      \"pmids\": [\"bio_10.1101_2024.11.08.622634\"],\n      \"is_preprint\": true\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"In congenic rat strains, introgression of the Milan hypertensive strain (MHS) Add1 gene into normotensive (MNS) background raised systolic blood pressure by ~10 mmHg, and replacing MHS Add1 with the MNS allele lowered SBP by ~10 mmHg, accounting for ~43% of the blood pressure difference between strains; Add2 and Add3 congenic strains showed no blood pressure effect.\",\n      \"method\": \"Reciprocal congenic strain development and blood pressure measurement (systolic blood pressure), chromosomal substitution mapping\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic epistasis via reciprocal congenic strains with quantitative phenotype; single lab, clean experimental design\",\n      \"pmids\": [\"15474463\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"ADD1 (α-adducin/SREBP1c) is a dual-function protein: in metabolic contexts it acts as a bHLH-leucine zipper transcription factor that binds E-box and SRE-1 elements (via a critical tyrosine in its basic domain) to activate lipogenic genes (FAS, ACC1, SCD1, 6PGDH) and PGC1α, produce PPARγ endogenous ligands, and is repressed by GSK3β-mediated phosphorylation and by physical interactions with Id2/Id3 and Twist2; in neuronal contexts it functions as an actin-capping/cytoskeletal protein required for synaptic AMPA receptor stabilization, memory consolidation, neural progenitor proliferation, and corpus callosum development, with ADD1 loss-of-function variants causing intellectual disability and brain malformations in humans.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"ADD1 encodes a dual-function protein that operates both as a sequence-specific transcription factor controlling lipogenic gene programs and, in distinct cellular contexts, as a cytoskeletal adducin governing neural development and synaptic plasticity [#0, #8, #10]. As a basic helix-loop-helix leucine zipper factor, ADD1/SREBP1 binds DNA through an atypical tyrosine in its basic region that confers dual recognition of canonical E-boxes and the non-E-box sterol regulatory element SRE-1 [#1], enabling direct transcriptional activation of lipogenic and metabolic targets including fatty acid synthase, ACC1, SCD1, 6-phosphogluconate dehydrogenase, and PGC1α [#0, #5, #6, #7]. It further drives adipogenic signaling by stimulating production of secreted endogenous lipid ligands that directly activate PPARγ [#2]. This transcriptional output is negatively regulated by GSK3β-mediated phosphorylation [#5] and by physical interactions with the dominant-negative HLH proteins Id2/Id3 and with Twist2, which block ADD1 DNA binding [#3, #4, #12]. In neural contexts, ADD1 functions through actin-capping activity to consolidate synaptic plasticity and stabilize AMPA-type glutamate receptors [#8], and to control the morphology and proliferation of neocortical progenitors [#13]. Human loss-of-function ADD1 variants cause intellectual disability, corpus callosum dysgenesis, and ventriculomegaly, phenotypes recapitulated in Add1 knockout mice, with patient variants impairing ADD1 protein expression and dimerization with ADD2 [#10]. ADD1 additionally translocates to the nucleus downstream of CTSB S-nitrosylation to recruit MATR3 and ADAR1, promoting A-to-I editing and stabilization of CTSB mRNA [#11].\",\n  \"teleology\": [\n    {\n      \"year\": 1993,\n      \"claim\": \"Established ADD1 as a novel bHLH-leucine zipper transcription factor that binds DNA and activates transcription in adipocytes, defining its identity as a sequence-specific regulator of adipogenic gene expression.\",\n      \"evidence\": \"Oligonucleotide cDNA library screening, CAT reporter assays, and DNA-binding specificity assays in adipocytes\",\n      \"pmids\": [\"8336713\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not define the full target gene set\", \"No structural basis for DNA recognition\"]\n    },\n    {\n      \"year\": 1995,\n      \"claim\": \"Resolved how ADD1 achieves dual DNA-binding specificity, showing a single atypical tyrosine in the basic region permits recognition of both E-box and SRE-1 elements, distinguishing it from canonical E-box-only bHLH factors.\",\n      \"evidence\": \"Site-directed mutagenesis of the bHLH basic region with bidirectional swap mutations and reporter assays in fibroblasts\",\n      \"pmids\": [\"7739539\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not establish which target genes use E-box versus SRE-1 in vivo\"]\n    },\n    {\n      \"year\": 1998,\n      \"claim\": \"Showed ADD1 acts upstream of PPARγ by inducing secreted endogenous lipid ligands, linking ADD1 transcriptional activity to a paracrine adipogenic signaling axis.\",\n      \"evidence\": \"Gal4-PPARγ chimeric reporter assays, conditioned medium transfer, and radioligand displacement binding\",\n      \"pmids\": [\"9539737\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Chemical identity of the endogenous ligand(s) not determined\", \"Biosynthetic enzymes downstream of ADD1 unidentified\"]\n    },\n    {\n      \"year\": 1999,\n      \"claim\": \"Identified Id2/Id3 as dominant-negative HLH antagonists that sequester ADD1 away from DNA, providing a mechanism for negative control of lipogenic activation.\",\n      \"evidence\": \"Reciprocal co-IP of in vitro-translated proteins, gel shift, and reporter assays in adipocytes and NIH-3T3 cells\",\n      \"pmids\": [\"10585876\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single lab\", \"Physiological conditions controlling Id2/Id3 levels not addressed\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Established Twist2 as an N-terminal-binding repressor of ADD1 that reduces DNA binding with a chromatin-modifying component, expanding the repertoire of ADD1 transcriptional repressors.\",\n      \"evidence\": \"Yeast two-hybrid screen, co-IP, DNA-binding and reporter assays, and HDAC inhibitor treatment\",\n      \"pmids\": [\"14654692\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single lab\", \"Identity of recruited HDAC not defined\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Demonstrated GSK3β directly phosphorylates ADD1 to suppress its transcriptional output, placing ADD1 under kinase-dependent post-translational control of lipogenesis.\",\n      \"evidence\": \"In vitro kinase and in vivo phosphorylation assays, GSK3 inhibition, GSK3β overexpression, and target gene readouts\",\n      \"pmids\": [\"15466874\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Phosphorylation sites not mapped\", \"Upstream signals controlling GSK3β toward ADD1 unclear\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Showed via reciprocal congenic rat strains that Add1 allelic variation causally contributes to blood pressure regulation, distinguishing it functionally from Add2 and Add3.\",\n      \"evidence\": \"Reciprocal congenic strain construction and systolic blood pressure measurement with chromosomal substitution mapping\",\n      \"pmids\": [\"15474463\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Molecular mechanism linking Add1 allele to blood pressure not defined\", \"Relationship to transcription factor vs cytoskeletal function unresolved\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Connected ADD1 to insulin/PI3-kinase signaling by demonstrating direct E-box-dependent activation of the 6PGDH gene, extending its targets to the pentose phosphate pathway.\",\n      \"evidence\": \"DNase I footprinting, promoter point mutation, reporter assays, and PI3-kinase inhibitor treatment\",\n      \"pmids\": [\"15896329\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single lab\", \"Direct phosphorylation events linking PI3K to ADD1 not shown\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Showed β-adrenergic signaling recruits ADD1 to a conserved E-box in the PGC1α promoter, linking ADD1 to thermogenic/mitochondrial transcriptional programs in brown-like adipocytes.\",\n      \"evidence\": \"Reporter assays, ChIP, and β-adrenergic stimulation in adipocyte models\",\n      \"pmids\": [\"19962449\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Cell-type-restricted cofactors required for activation unidentified\", \"Single lab\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Revealed a distinct cytoskeletal role for ADD1 in neurons, showing α-adducin actin-capping activity is required to consolidate synaptic plasticity and stabilize AMPA receptors during memory storage.\",\n      \"evidence\": \"C. elegans add-1 loss-of-function genetics, olfactory conditioning behavior, GLR-1 imaging and FRAP, and human ADD1 rescue\",\n      \"pmids\": [\"22307086\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanistic link between actin-capping and receptor retention not fully resolved\", \"Mammalian synaptic validation limited\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Defined non-erythroid requirements for α-adducin in vivo, with Add1 knockout mice showing skeletal, esophageal, and peripheral nerve phenotypes.\",\n      \"evidence\": \"Add1 null mouse histology of spine and esophagus and peripheral nerve axon counts\",\n      \"pmids\": [\"22926980\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No molecular mechanism identified\", \"Tissue-specific contributions not dissected\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Established ADD1 as a human disease gene, with loss-of-function variants causing intellectual disability and brain malformations through impaired ADD1 expression and ADD2 dimerization.\",\n      \"evidence\": \"Exome and RNA sequencing, super-resolution imaging, immunoblotting, in vitro ADD1–ADD2 dimerization assays, and Add1 knockout mouse recapitulation\",\n      \"pmids\": [\"34906466\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Cellular mechanism linking dimerization loss to corpus callosum dysgenesis incomplete\", \"Splice-isoform-specific functions not fully defined\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Uncovered a nuclear RNA-regulatory function for ADD1, in which dephosphorylation-driven nuclear translocation recruits MATR3 and ADAR1 to promote A-to-I editing and stabilization of CTSB mRNA.\",\n      \"evidence\": \"S-nitrosylation assays, nuclear fractionation, co-IP of the ADD1–MATR3–ADAR1 complex, RNA editing and stability assays, and HuR binding assays\",\n      \"pmids\": [\"37156877\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single lab without independent replication\", \"Generality beyond CTSB unknown\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Identified CHRDL1 as an ADD1 transcriptional target and showed TWIST2, but not TWIST1, competes at the shared E-box, refining the specificity of Twist-family repression of ADD1.\",\n      \"evidence\": \"EMSA, luciferase reporter assays, and EMSA competition with TWIST2/TWIST1 and disease-mutant variants\",\n      \"pmids\": [\"37761873\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single lab\", \"In vivo relevance of CHRDL1 regulation not established\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Linked ADD1 to neocortical expansion by showing adducins regulate basal progenitor morphology and proliferative capacity across species.\",\n      \"evidence\": \"Mouse and ferret in vivo neocortex electroporation, human cortical organoid ADD1 knockout, and imaging/cell counting (preprint)\",\n      \"pmids\": [\"bio_10.1101_2024.11.08.622634\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Preprint, not yet peer-reviewed\", \"Molecular mechanism connecting adducin to progenitor proliferation unresolved\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How the same protein partitions between its transcription-factor and cytoskeletal/RNA-regulatory roles, and what controls isoform- and tissue-specific deployment, remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No unified model reconciling metabolic transcription factor and neuronal adducin functions\", \"Determinants of subcellular partitioning (nucleus vs cytoskeleton) undefined\", \"Isoform-specific functional assignment incomplete\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0003677\", \"supporting_discovery_ids\": [0, 1, 5, 6, 7, 12]},\n      {\"term_id\": \"GO:0140110\", \"supporting_discovery_ids\": [0, 2, 5, 7, 12]},\n      {\"term_id\": \"GO:0008092\", \"supporting_discovery_ids\": [8, 13]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [11]},\n      {\"term_id\": \"GO:0005856\", \"supporting_discovery_ids\": [8]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"GO:0140110\", \"supporting_discovery_ids\": [0, 5]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\"PPARG\", \"ID2\", \"ID3\", \"TWIST2\", \"GSK3B\", \"ADD2\", \"MATR3\", \"ADAR1\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":7,"faith_total":7,"faith_pct":100.0}}